This from the Washington Post via Joe Mills. The fact is, it’s cheaper and more profitable to market drugs for long term maladies than for infectious disease.
Superbugs expose lack of antibiotic research
On diabetic foot, wound healing, amputation prevention, and the merger of consumer tech with medical devices